Skip to main content
. 2014 Jul 17;14(8):1817–1827. doi: 10.1111/ajt.12810

Table 4.

Causes of death

Treatment group Age/sex Reported cause of death Study day
Basiliximab + belatacept HD + MMF 57/M Sepsis 18
61/M Myocardial infarction 23
49/M Multiple system organ failure 25
56/M Sepsis 127
Belatacept HD + MMF 43/M Sepsis 24
37/M Sepsis 84
62/F Multiple system organ failure 111
47/M Gastrointestinal bleed 147
62/F Unknown 274
58/M Unknown 278
51/M PML 322
Belatacept LD + MMF 65/M Multiple system organ failure 2
59/F Colon perforation 8
48/M Acute hepatic failure 16
63/F Pulmonary failure 21
53/M Sepsis 65
50/M Gunshot injury 117
58/F Multiple system organ failure 202
55/M Multiple system organ failure 208
65/F Multiple system organ failure 339
51/M PTLD 364
Tacrolimus + MMF 54/M Sepsis 168
Tacrolimus 49/M Myocardial infraction 34
52/M Multiple system organ failure 63
46/M Gastrointestinal bleed 68
49/M Sepsis 286

F, female; HD, high dose, LD, low dose; M, male; MMF, mycophenolate mofetil; PML, progressive multifocal leukoencephalopathy; PTLD, posttransplant lymphoproliferative disease.